HIV This Week

Long-term costs and health impact of continued global fund support for antiretroviral therapy

Stover J, Korenromp EL, Blakley M, Komatsu R, Viisainen K, Bollinger L, Atun R. PLoS One. 2011;6(6):e21048.

The effects of national and international HIV/AIDS funding and governance mechanisms on the development of civil-society responses to HIV/AIDS in East and Southern Africa

Kelly KJ, Birdsall K. AIDS Care. 2010;22 Suppl 2:1580-7

Drivers of inequality in millennium development goal progress statistical analysis

Stuckler D, Basu S, McKee M. PLoS Med. 2010;7:e1000241.

Estimation of antiretroviral therapy coverage: methodology and trends.

Mahy M, Tassie JM, Ghys PD, Stover J, Beusenberg M, Akwara P, Souteyrand Y. Curr Opin HIV AIDS. 2010 5:97-102.

How can we support the use of systematic reviews in policymaking?

Lavis JN. PLoS Med. 2009;6:e1000141. Epub 2009 Nov 17.

"Talkin' about a revolution": How electronic health records can facilitate the scale-up of HIV care and treatment and catalyze primary care in resource-constrained settings.

Braitstein P, Einterz RM, Sidle JE, Kimaiyo S, Tierney W. J Acquir Immune Defic Syndr. 2009 Nov;52(S1).

Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

Heffelfinger JD, Patel P, Brooks JT, Calvet H, Daley CL, Dean HD, Edlin BR, Gensheimer KF, Jereb J, Kent CK, Lennox JL, Louie JK, Lynfield R, Peters PJ, Pinckney L, Spradling P, Voetsch AC, Fiore A. Am J Public Health 2009; 99(S2)

Are We on Course for Reporting on the Millennium Development Goals in 2015?

Rugg D, Marais H, Law BA, Carael M, De Lay P, and, Warner-Smith M. J Acquir Immune Defic Syndr. 2009;52(S2)

Changing global essential medicines norms to improve access to AIDS treatment: lessons from Brazil. Nunn A, Fonseca ED, Gruskin S. Glob Public Health. 2009;4:131-49.

Bendavid E, Bhattacharya J. The President’s Emergency Plan for AIDS Relief in Africa: An Evaluation of Outcomes. Ann Intern Med. 2009 Apr 6. [Epub ahead of print]